Skip to main content
CancerCell TherapyIndustryNew Technologies

Ep. 60: “Stemcentrx” Featuring Scott Dylla

By December 22, 2015March 31st, 2023One Comment

Guest:

Scott Dylla, CSO and co-founder of Stemcentrx, a really cool new company that is using novel technology to target stem cells as a therapy for different cancers, joins us for the interview portion.

Happy Holidays and New Year!

Photo Reference: Courtesy of Scott Dylla

Subscribe to our newsletter!

Never miss updates about new episodes.

Subscribe

One Comment

  • HSC says:

    I’m having trouble finding the reference for the shRNA screen in MSCs for stem cell regulator and differentiation factors. Can you please upload a link?